Testing treatments to improve symptoms of Myositis

Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Study location

Wesley Research Institute

Study type

Industry Sponsored

Patient group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Industry sponsor

Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

About this clinical trial

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

  Lead investigator  
          Dr Daman Langguth      

  Clinical trial coordinator  
          Venita Bali      

Register your interest

If you would like more information about this clinical trial, please complete the contact form below.

Name(Required)

Email(Required)

Phone*(Required)

Date(Required)

Would you like to be updated on the progress of our research?(Required)

Yes

No

Message

CAPTCHA

I consent to receive updates on Wesley Research Institute news and events, clinical trials, research projects and how to support WRI.

Yes

By submitting this form you consent for us to hold your information in accordance with our Privacy Policy

Comments

This field is for validation purposes and should be left unchanged.